Marinus Pharmaceuticals, Inc
MRNS
MRNS was delisted on the 10th of February, 2025.
27 hedge funds and large institutions have $73.2M invested in Marinus Pharmaceuticals, Inc in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 6 closing their positions.
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
39% more capital invested
Capital invested by funds: $52.8M → $73.2M (+$20.4M)
29% more funds holding
Funds holding: 21 → 27 (+6)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.19M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.99M |
| 3 |
NLVP
New Leaf Venture Partners
New York
|
+$1.21M |
| 4 |
Goldman Sachs
New York
|
+$836K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$794K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$1.88M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$1.42M |
| 3 |
AIC
AWM Investment Company
New York
|
-$1.19M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$325K |
| 5 |
Morgan Stanley
New York
|
-$156K |
MRNS Hedge Fund Activity: Q2 2015 in Review
27 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Marinus Pharmaceuticals, Inc (MRNS) for Q2 2015, worth a combined $73.2M — up 39% from $52.8M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new MRNS positions and 6 closed out — a net gain of 6 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $2.19M. The largest seller was Emerald Advisers, cutting an estimated $1.88M.
- 27 institutional investors held Marinus Pharmaceuticals, Inc (MRNS) as of Q2 2015, up from 21 in Q1 2015.
- Funds reported $73.2M of Marinus Pharmaceuticals, Inc stock for Q2 2015, up 39% quarter-over-quarter.
- 12 funds opened new Marinus Pharmaceuticals, Inc positions in Q2 2015 and 6 closed out, a net change of +6 holders.
- The largest Marinus Pharmaceuticals, Inc buyer in Q2 2015 was Point72 Asset Management, an estimated $2.19M added.
- The largest Marinus Pharmaceuticals, Inc seller in Q2 2015 was Emerald Advisers, an estimated $1.88M sold.
Based on aggregated 13F filings for Q2 2015.